Skip to content

Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit

Prospective Cohort Study on Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04503135
Acronym
CAAT
Enrollment
203
Registered
2020-08-07
Start date
2020-09-01
Completion date
2022-10-21
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Venous Catheters, Central Venous Catheter Thrombosis, Intensive Care Unit, Thrombosis, Venous

Brief summary

This study aims to describe the incidence of catheter-related and non-catheter-related thrombosis in a population of adults in ICU and to assess its correlation with alteration of coagulation parameters.

Detailed description

Central venous catheter (CVC) is now indispensable in the monitoring and care of patients in intensive care (ICU). Unfortunately, one of the complications of its positioning is catheter-related thrombosis (CRT) and its consequences. Despite the widespread use of CVC and the extensive literature describing its complications, areas of uncertainty regarding the onset, treatment and prevention of CRT persist, especially with regard to asymptomatic thrombosis. This study aims to describe the incidence of catheter-related and non-catheter-related thrombosis in a population of adults in ICU and to assess its correlation with alteration of coagulation parameters. The main objective of this study is to assess the proportion of patients developing CRT (proportion) and the incidence of CRT (rate expressed in catheter events/days) in patients in ICU.

Interventions

DIAGNOSTIC_TESTultrasound

ultrasound of the central veins of the neck and chest and a (compression ultra-sound) CUS of the femoral veins will be performed bilaterally

Sponsors

Policlinico Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients over the age of 18 * admitted to intensive care who have for clinical reasons need to place a central venous catheter * signing of informed consent

Exclusion criteria

* patients under 18 years of age * Known cancer status * Congenital thrombophilia

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients developing Catheter related thrombosis and Incidence of CRT in patients in ICUUntil CVC removalThe main objective of this study is to assess the proportion of patients developing CRT (proportion) and the incidence of CRT (rate expressed in catheter events/days) in patients in ICU.

Secondary

MeasureTime frameDescription
Proportion of various types of thrombotic appositionUntil CVC removalThe proportion of various types of thrombotic apposition
Deep venous thrombosis (DVT) proportion and IncidenceUntil CVC removalThe proportion of patients developing DVT and the incidence of catheter-related DVT (rate) in patients in ICU carrying CVC.
the association of thrombosis with alterations of hemocoagulative parametersUntil CVC removalthe association of thrombosis with alterations of hemocoagulative parameters
describe the clinical measures that have been taken following the diagnosis of CRT.describe the clinical measures that have been taken following the diagnosis of CRT.Until CVC removaldescribe the clinical measures that have been taken following the diagnosis of CRT.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026